1.Clinical characteristics of Mycoplasma pneumoniae pneumonia in 161 patients
Tao JI ; Guojing HAN ; Yuxiang SONG ; Heng ZHANG ; Yanning MA ; Hanpu GONG ; Jinxi YU ; Gang LIU ; Yifan ZHU ; Yongzhi ZHAI ; Haiyan ZHU
Chinese Journal of Nosocomiology 2025;35(10):1478-1482
OBJECTIVE To explore the clinical characteristics of Mycoplasma pneumoniae pneumonia(MPP)after COVID-19 epidemic so as to offer help for early clinical diagnosis and treatment.METHODS The clinical data that were collected from the MPP patients who were treated in the fever clinic of the First Medical Center of Chinese PLA General Hospital from Jul.2023 to Aug.2024 were retrospectively analyzed.The results of laboratory tests for the different age groups of patients complicated with other pathogens were statistically analyzed.RESULTS Of totally 161 MPP patients who were enrolled in the study,78(48.85%)were male,and 83(51.55%)were fe-male;the average age was(32.98±14.35)years old,and the patients aged between 20 and 40 years old accoun-ted for 43.48%(70 cases).The enrolled patients were divided into the simple MPP group with 92(57.14%)ca-ses and the MPP+mixed group with 69(42.86%)cases according to the result of etiological test of sputum;the patients of MPP+mixed group were divided into the MPP+bacteria group with 42(60.87%)cases,the MPP+fungi group with 10(14.49%)cases,and the MPP+viruses group with 17(24.64%)cases.There was significant difference in the age among the groups(P<0.05);there were no significant differences in the sex,white blood cell counts and percentage of mononuclear cells among the groups,the percentage of lymphocytes was highest in the simple MPP group,the levels of C-reactive protein(CRP)and interleukin-6(IL-6)were highest in the MPP+bacteria group,and there were significant differences(P<0.05).All of the patients were divided into three groups:the ≤20-year-old group the>20-40-year old group and the>40-year-old group.There were no sig-nificant differences in the white blood cell counts,percentage of lymphocytes,percentage of mononuclear cells and IL-6 level among the three groups,and the CRP level was highest in the>20-40-year old group(P=0.025).Ran-dom forest model analysis showed that the weight of CRP was highest(22.65%)among the clinical characteristics of the MPP patients,which played a key role in construction of model.As for other factors,the weight of age was 17.02%,the percentage of lymphocytes 15.34%,the white blood cells counts 14.86%,the percentage of mono-nuclear cells 14.39%,the IL-6 13.61%,the gender 2.13%.CONCLUSION MPP maintains common among the patients aged less than 40 years old after the COVID-19 epidemic,nearly half of the patients are complicated with the infections of other pathogens,and CRP is more helpful for the clinical diagnosis and treatment of the MPP in early stage.
2.Clinical characteristics and treatment of 34 patients with non-severe Chlamydia psittaci pneumonia
Tao JI ; Lili WANG ; Tingting XU ; Yuxiang SONG ; Heng ZHANG ; Hanpu GONG ; Jinxi YU ; Yan-ning MA ; Yifan ZHU ; Yongzhi ZHAI ; Guojing HAN
Chinese Journal of Nosocomiology 2025;35(14):2091-2094
OBJECTIVE To summarize the clinical characteristics and diagnosis and treatment experiences in dealing with non-severe Chlamydia psittaci pneumonia.METHODS The clinical data were collected from 34 patients who were diagnosed with non-severe C.psittaci pneumonia through quantitative polymerase chain reactiong(qPCR)for sputum in fever clinic of the First Medical Center of Chinese PLA General Hospital from Mar.2023 to Mar.2024 and were retrospectively analyzed.The clinical characteristics and treatment outcomes were evaluated.RESULTS The average age of the patients was(44.82±13.74)years old,the ratio of male to female was 1∶1.83;all of the patients had fever;major symptoms were cough(70.59%),pharyngodynia(44.12%),and flu-like symptoms(41.18%);82.35%of the patients had the history of contact with poultry.The C-reactive pro-tein(CRP)level,interleukin-6(IL-6),systemic inflammatory response index(SIRI)and aggregate index of sys-temic inflammation(AISI)were higher among the patients aged no less than 44 years old than among the patients less than 44 years old(P<0.05);the percentage of lymphocytes of the patients aged no less than 44 years old was lower than that of the patients aged less than 44 years old(P<0.05).As for the imaging findings,73.53%of the patients had consolidation shadows,26.47%had ground-glass opacities,and 32.35%involved both lungs.All of the patients received quinolones or tetracyclines for treatment of 7-14 days and all symptoms relieved.CT reexami-nated 1 month after the treatment showed that 55.88%of the cases had complete absorption of pulmonary infec-tious lesions,and 35.29%had partial absorption.CONCLUSIONS The patients with non-severe Chlamydia psitta-ci pneumonia are characterized by the history of contact with poultry,fever complicated with respiratory tract symptoms,rise of inflammatory markers(more significant among patients of advanced age)and lower lobe con-solidation shadow/ground-glass opacities.Early identification and standardized treatment may facilitate the favora-ble treatment outcomes.
3.Epidemic characteristics and temporal-spatial trends of human anthrax in Shaanxi Province from 1955 to 2024
Guojing YANG ; Shu WANG ; Xinxin LI ; Mengyan ZHANG ; Yunpeng NIAN
Chinese Journal of Endemiology 2025;44(10):809-814
Objective:To learn about the epidemic characteristics and temporal-spatial trends of human anthrax in Shaanxi Province, and to provide a theoretical basis for prevention and control of anthrax.Methods:The epidemic data of human anthrax in Shaanxi Province from 1955 to 2024 were collected for descriptive epidemiological analysis. Joinpoint regression model was used to analyze the trend of anthrax incidence rate. The trend at all times and different intervals were estimated by average annual percent change (AAPC) and annual percent change (APC), respectively. Based on the number of human anthrax cases in each county (district) of Shaanxi Province from 1980 to 2024, datasets were constructed in segments every five years for global and local spatial autocorrelation analysis.Results:From 1955 to 2024, a total of 3 900 cases of human anthrax were reported in Shaanxi Province, with 124 deaths. The average annual incidence rate was 0.18/100 000 and the fatality rate was 3.18%. The incidence rate of human anthrax generally showed a downward trend (AAPC = - 3.21, t = - 1.99, P = 0.044), with the fastest decline rate from 1977 to 1993 (APC = - 15.24, t = - 4.08, P < 0.001). A temporal and regional distribution analysis was conducted on 484 human anthrax cases in Shaanxi Province from 1980 to 2024. The peak period of incidence was from July to September, accounting for 52.27% (253/484). The cities with a relatively high number of reported cases were Weinan City (201 cases), Xianyang City (161 cases), and Xi'an City (77 cases), accounting for a total of 90.70% (439/484). A population distribution analysis was conducted on 93 human anthrax cases in Shaanxi Province from 2005 to 2024, with 73 males (78.49%) and 20 females (21.51%), resulting in a male to female ratio of 3.65 ∶ 1.00. The age range was 13 to 79 years old, with a median of 44 years old. The age group of 35 to 59 years old had a higher case of the disease, accounting for 65.59% (61/93). Farmers were the main occupation, accounting for 87.10% (81/93). The shortest time interval between onset and diagnosis of 93 human anthrax cases was 0 days, the longest was 47 days, and the median was 5 days. The results of global spatial autocorrelation analysis showed that there was spatial positive correlation in human anthrax cases from 1980 to 1984, 1985 to 1989, 2000 to 2004, and 2020 to 2024 (global Moran's I > 0, Z > 1.96, P < 0.05). The results of local spatial autocorrelation analysis showed that the high-high aggregation area of human anthrax cases was concentrated in the Guanzhong region. Conclusions:From 1955 to 2024, the incidence rate of human anthrax in Shaanxi Province generally shows a downward trend. The peak period of incidence is from July to September, and the affected populations are mainly middle-aged male farmers. Human anthrax cases from 1980 to 1984, 1985 to 1989, 2000 to 2004 and 2020 to 2024 show spatial clustering, with high-high clustering areas concentrated in the Guanzhong region.
4.Apelin:A new target for the prevention and treatment of chronic kid-ney disease
Chengguo LYU ; Caiqian WU ; Qianrui MI ; Guojing ZHANG ; Ling LI ; Qifa YE
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(9):1243-1252
Chronic kidney disease(CKD)is a chronic renal structural and functional disorder caused by multiple causes(history of kidney injury>3 months),with complex etiology and high inci-dence,which will eventually lead to end-stage re-nal disease(ESRD).Common chronic kidney diseas-es include diabetic nephropathy,polycystic ne-phropathy,nephrogenic diabetes insipidus and re-nal fibrosis.At present,there is still a lack of effec-tive specific treatment for chronic kidney disease.The Apelin system is an endogenous physiological regulator.Studies have shown that Apelin is in-volved in the occurrence and development of the above diseases mainly through the regulation of kidney body fluids and blood vessels,and the regu-lation of kidney glucose and lipid metabolism and immunity.This article aims to review the role of Apelin in chronic kidney diseases in recent years,and provide ideas for the treatment and drug de-velopment of kidney diseases with Apelin as a new target.
5.Clinical characteristics of Mycoplasma pneumoniae pneumonia in 161 patients
Tao JI ; Guojing HAN ; Yuxiang SONG ; Heng ZHANG ; Yanning MA ; Hanpu GONG ; Jinxi YU ; Gang LIU ; Yifan ZHU ; Yongzhi ZHAI ; Haiyan ZHU
Chinese Journal of Nosocomiology 2025;35(10):1478-1482
OBJECTIVE To explore the clinical characteristics of Mycoplasma pneumoniae pneumonia(MPP)after COVID-19 epidemic so as to offer help for early clinical diagnosis and treatment.METHODS The clinical data that were collected from the MPP patients who were treated in the fever clinic of the First Medical Center of Chinese PLA General Hospital from Jul.2023 to Aug.2024 were retrospectively analyzed.The results of laboratory tests for the different age groups of patients complicated with other pathogens were statistically analyzed.RESULTS Of totally 161 MPP patients who were enrolled in the study,78(48.85%)were male,and 83(51.55%)were fe-male;the average age was(32.98±14.35)years old,and the patients aged between 20 and 40 years old accoun-ted for 43.48%(70 cases).The enrolled patients were divided into the simple MPP group with 92(57.14%)ca-ses and the MPP+mixed group with 69(42.86%)cases according to the result of etiological test of sputum;the patients of MPP+mixed group were divided into the MPP+bacteria group with 42(60.87%)cases,the MPP+fungi group with 10(14.49%)cases,and the MPP+viruses group with 17(24.64%)cases.There was significant difference in the age among the groups(P<0.05);there were no significant differences in the sex,white blood cell counts and percentage of mononuclear cells among the groups,the percentage of lymphocytes was highest in the simple MPP group,the levels of C-reactive protein(CRP)and interleukin-6(IL-6)were highest in the MPP+bacteria group,and there were significant differences(P<0.05).All of the patients were divided into three groups:the ≤20-year-old group the>20-40-year old group and the>40-year-old group.There were no sig-nificant differences in the white blood cell counts,percentage of lymphocytes,percentage of mononuclear cells and IL-6 level among the three groups,and the CRP level was highest in the>20-40-year old group(P=0.025).Ran-dom forest model analysis showed that the weight of CRP was highest(22.65%)among the clinical characteristics of the MPP patients,which played a key role in construction of model.As for other factors,the weight of age was 17.02%,the percentage of lymphocytes 15.34%,the white blood cells counts 14.86%,the percentage of mono-nuclear cells 14.39%,the IL-6 13.61%,the gender 2.13%.CONCLUSION MPP maintains common among the patients aged less than 40 years old after the COVID-19 epidemic,nearly half of the patients are complicated with the infections of other pathogens,and CRP is more helpful for the clinical diagnosis and treatment of the MPP in early stage.
6.Clinical characteristics and treatment of 34 patients with non-severe Chlamydia psittaci pneumonia
Tao JI ; Lili WANG ; Tingting XU ; Yuxiang SONG ; Heng ZHANG ; Hanpu GONG ; Jinxi YU ; Yan-ning MA ; Yifan ZHU ; Yongzhi ZHAI ; Guojing HAN
Chinese Journal of Nosocomiology 2025;35(14):2091-2094
OBJECTIVE To summarize the clinical characteristics and diagnosis and treatment experiences in dealing with non-severe Chlamydia psittaci pneumonia.METHODS The clinical data were collected from 34 patients who were diagnosed with non-severe C.psittaci pneumonia through quantitative polymerase chain reactiong(qPCR)for sputum in fever clinic of the First Medical Center of Chinese PLA General Hospital from Mar.2023 to Mar.2024 and were retrospectively analyzed.The clinical characteristics and treatment outcomes were evaluated.RESULTS The average age of the patients was(44.82±13.74)years old,the ratio of male to female was 1∶1.83;all of the patients had fever;major symptoms were cough(70.59%),pharyngodynia(44.12%),and flu-like symptoms(41.18%);82.35%of the patients had the history of contact with poultry.The C-reactive pro-tein(CRP)level,interleukin-6(IL-6),systemic inflammatory response index(SIRI)and aggregate index of sys-temic inflammation(AISI)were higher among the patients aged no less than 44 years old than among the patients less than 44 years old(P<0.05);the percentage of lymphocytes of the patients aged no less than 44 years old was lower than that of the patients aged less than 44 years old(P<0.05).As for the imaging findings,73.53%of the patients had consolidation shadows,26.47%had ground-glass opacities,and 32.35%involved both lungs.All of the patients received quinolones or tetracyclines for treatment of 7-14 days and all symptoms relieved.CT reexami-nated 1 month after the treatment showed that 55.88%of the cases had complete absorption of pulmonary infec-tious lesions,and 35.29%had partial absorption.CONCLUSIONS The patients with non-severe Chlamydia psitta-ci pneumonia are characterized by the history of contact with poultry,fever complicated with respiratory tract symptoms,rise of inflammatory markers(more significant among patients of advanced age)and lower lobe con-solidation shadow/ground-glass opacities.Early identification and standardized treatment may facilitate the favora-ble treatment outcomes.
7.Role of autophagy in treatment of paracetamol-induced liver injury
Guojing XING ; Lifei WANG ; Longlong LUO ; Xiaofeng ZHENG ; Chun GAO ; Xiaohui YU ; Jiucong ZHANG
Journal of Clinical Hepatology 2025;41(2):389-394
N-acetyl-p-aminophenol (APAP) is an antipyretic analgesic commonly used in clinical practice, and APAP overdose can cause severe liver injury and even death. In recent years, the incidence rate of APAP-induced liver injury (AILI) tends to increase, and it has become the second most common cause of liver transplantation worldwide. Autophagy is a highly conserved catabolic process that removes unwanted cytosolic proteins and organelles through lysosomal degradation to achieve the metabolic needs of cells themselves and the renewal of organelles. A large number of studies have shown that autophagy plays a key role in the pathophysiology of AILI, involving the mechanisms such as APAP protein conjugates, oxidative stress, JNK activation, mitochondrial dysfunction, inflammatory response and apoptosis. This article elaborates on the biological mechanism of autophagy in AILI, in order to provide a theoretical basis for the treatment of AILI and the development of autophagy regulators.
8.The roles of eosinophils in different liver diseases
Guojing XING ; Yuan DENG ; Lifei WANG ; Longlong LUO ; Zhen WANG ; Zhaojie ZHANG ; Meixia YANG ; Ting ZHANG ; Xiaohui YU ; Jiucong ZHANG
Journal of Clinical Hepatology 2025;41(7):1456-1460
Liver diseases have a high prevalence rate worldwide with relatively poor long-term clinical outcomes and have become one of the leading causes of disease burden and death around the world,which poses significant challenges to public health.Eosinophils(Eos)are a class of highly conserved multifunctional immune cells that play critical effector roles in allergic diseases.In recent years,an increasing amount of evidence has shown that Eos plays an important role in the pathogenesis of liver diseases,exerting a protective or harmful effect in different liver diseases,which has become a research hotspot in this field.This article elaborates on the role and potential mechanism of action of Eos in liver diseases,in order to provide a new perspective for in-depth research on the pathogenesis of liver diseases and lay the foundation for developing therapeutic strategies targeting Eos.
9.The roles of eosinophils in different liver diseases
Guojing XING ; Yuan DENG ; Lifei WANG ; Longlong LUO ; Zhen WANG ; Zhaojie ZHANG ; Meixia YANG ; Ting ZHANG ; Xiaohui YU ; Jiucong ZHANG
Journal of Clinical Hepatology 2025;41(7):1456-1460
Liver diseases have a high prevalence rate worldwide with relatively poor long-term clinical outcomes and have become one of the leading causes of disease burden and death around the world,which poses significant challenges to public health.Eosinophils(Eos)are a class of highly conserved multifunctional immune cells that play critical effector roles in allergic diseases.In recent years,an increasing amount of evidence has shown that Eos plays an important role in the pathogenesis of liver diseases,exerting a protective or harmful effect in different liver diseases,which has become a research hotspot in this field.This article elaborates on the role and potential mechanism of action of Eos in liver diseases,in order to provide a new perspective for in-depth research on the pathogenesis of liver diseases and lay the foundation for developing therapeutic strategies targeting Eos.
10.Farnesoid X receptor: a novel target for renal immune regulation
Caiqian WU ; Chengguo LYU ; Qianrui MI ; Guojing ZHANG ; Ling LI ; Qifa YE
Chinese Journal of Nephrology 2025;41(10):782-787
Immune-related kidney disease is one of the causes of end-stage renal disease and an important disease type that threatens public health. Farnesoid X receptor (FXR) is a nuclear receptor activated by bile acids, involved in regulating gene expression related to bile acid, lipid, and glucose metabolism. In recent years, the role of FXR in renal immune regulation has received attention. FXR participates in the occurrence and development of immune-related kidney diseases by regulating the differentiation, polarization, activation, recruitment, adhesion, infiltration, and cytokine release of immune cells such as macrophages, dendritic cells, natural killer cells, T lymphocytes, and B lymphocytes. This article reviews renal immune-regulatory mechanisms of FXR in recent years and its potential role in immune-related kidney diseases, to provide a theoretical basis for the prevention and treatment of immune-related kidney diseases targeting FXR.

Result Analysis
Print
Save
E-mail